Your browser doesn't support javascript.
loading
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Ruscito, Ilary; Darb-Esfahani, Silvia; Kulbe, Hagen; Bellati, Filippo; Zizzari, Ilaria Grazia; Rahimi Koshkaki, Hassan; Napoletano, Chiara; Caserta, Donatella; Rughetti, Aurelia; Kessler, Mirjana; Sehouli, Jalid; Nuti, Marianna; Braicu, Elena Ioana.
Afiliação
  • Ruscito I; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353 Berlin, Germany; Cell Therapy Unit and Laboratory of Tum
  • Darb-Esfahani S; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
  • Kulbe H; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Bellati F; Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Zizzari IG; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Rahimi Koshkaki H; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Napoletano C; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Caserta D; Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Rughetti A; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Kessler M; Department of Molecular Biology, Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany.
  • Sehouli J; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Nuti M; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Braicu EI; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Gynecol Oncol ; 150(1): 151-157, 2018 07.
Article em En | MEDLINE | ID: mdl-29753392
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Retinal Desidrogenase / Isoenzimas Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Retinal Desidrogenase / Isoenzimas Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article